Nestle is using artificial intelligence and nutritional science to develop products for the millions of Americans taking GLP-1 weight-loss drugs such as Ozempic and Wegovy, aiming to turn the rise of …
Enterprises rushing to deploy generative and agentic AI are repeating mistakes from the RPA era, according to technology leaders at Globant, Novo Nordisk, and Purpose Legal. Agustin Huerta, SVP of dig…
Abbott launched Libre Assist, an AI-powered tool using image recognition to predict how meals affect glucose levels, at CES on January 5, 2026. The feature extends the FreeStyle Libre continuous gluco…
Novo Nordisk and Amazon Web Services (AWS) have entered a strategic partnership to accelerate drug discovery using AI agents and cloud technology, and have established a jointly owned innovation hub i…
SpaceX (SPCX) will report its first earnings as a public company on Tuesday, with shares down nearly 30% from their $150 IPO debut last month. The July jobs report, due Friday, is expected to show 88,…
Denmark's Centre for Biosecurity and Biopreparedness (CBB) assesses that current AI chatbots pose limited bioweapon risk to novices due to hallucinations, but offer significant advantages to competent…
A secret shopper survey by Yale University researchers published in JAMA found that nearly half of 49 online GLP-1 telehealth providers failed to ask about diet, physical activity, or eating disorders…
Anthropic's expansion into science tooling and drug discovery is raising enterprise competition concerns among clients who worry the AI vendor may become a competitor. The concerns, reported by BetaKi…
Anthropic announced a new science-focused AI model and plans to develop drugs itself, prompting Palantir's Alex Karp and others to warn enterprises that the company could become a competitor after acc…
Novo Nordisk, a Danish pharmaceutical company, struggles to measure the return on investment of generative AI due to complex, multi-step drug development processes. The company uses AI-powered digital…
Bernstein raised its price target for ASML to $2,623, implying 48% upside, despite the stock more than doubling in the past year. The Dutch semiconductor equipment maker is Europe's most valuable comp…
Microsoft announced Microsoft Frontier Company, a new operating business focused on AI-driven transformation, backed by a $2.5 billion investment and 6,000 industry and engineering experts. The compan…
Microsoft launched Microsoft Frontier Company, a new business unit dedicated to AI-driven enterprise transformation, backed by a $2.5 billion investment and 6,000 embedded experts. The unit combines i…
Eli Lilly invested $40 million in Absci, a generative AI drug company, to develop ABS-201, an injectable antibody for baldness and endometriosis. The deal, part of a $100 million stock offering, aims …
European companies ASML, Novo Nordisk, and Mistral have achieved global leadership in advanced chips, obesity drugs, and open-source AI despite a venture capital pool 75% smaller than the US and €700 …
Space X was the most bought stock on Swedish online brokers Avanza and Nordnet in June, driven by AI and space interest. Avanza customers sold Sivers Semiconductors for the fourth consecutive month, t…
Nordic stock exchanges fell on Tuesday, led by declines in technology and AI-related stocks. Oslo's OBX index dropped 0.1%, with Norsk Hydro falling 3.8% and Nordic Semiconductor down 4.7%. Copenhagen…
Nadia Carlsten, former AWS executive, became CEO of Smartbird (formerly Allbirds) after the company pivoted to AI infrastructure, selling its shoe business for $43 million and raising $100 million. Sm…
Cyber extortion group FulcrumSec claimed on Tuesday to have stolen over a terabyte of data from pharmaceutical giant Novo Nordisk and attempted a $25 million extortion. The group said it is now explor…
GLP-1 drug use peaks in middle age, with 22% of adults aged 50-64 taking them, then drops sharply to 9% at age 65 due to Medicare's ban on covering weight-loss medications. The overall adult usage rat…